Stocksigma LogoStocksigma Logo

Aptus Pharma Approves ₹44.73 Crore Preferential Equity Allotment

Aptus Pharma Limited approved the preferential allotment of 15,97,470 equity shares at an issue price of ₹280 per share (face value ₹10 plus ₹270 premium)

Aptus Pharma Approves ₹44.73 Crore Preferential Equity Allotment

Aptus Pharma Ltd · Outcome · 12 Nov 2026, 6:17 pm

Aptus Pharma Approves ₹44.73 Crore Preferential Equity Allotment Aptus Pharma Limited approved the preferential allotment of 15,97,470 equity shares at an issue price of ₹280 per share (face value ₹10 plus ₹270 premium) on 12th Nov'26, raising ₹44.73 crore across 188 allottees for cash. Consequently, paid-up equity capital increased from ₹17.15 crore (1.715 crore shares) to ₹18.75 crore (1.875 crore shares). The allotment follows shareholder approval on 14th Sep'26 and BSE in-principle approval on 30th Oct'26, adjusted from an initial 16.03 lakh shares due to non-subscription by two proposed allottees.

Original exchange filing (PDF)

More announcements from Aptus Pharma Ltd

All Aptus Pharma Ltd announcements